MyFinsight
Home
Blog
About
Sales and maturities
of investments
$49,250K
(61.48%↑ Y/Y)
Gain on sale of prv
-$43,314K
(-129.20%↓ Y/Y)
Payments for employee
taxes related to stock...
-$1,150K
Proceeds from employee
stock purchase plan
$434K
(5.08%↑ Y/Y)
Proceeds from issuance of
common stock for...
$1K
(-99.97%↓ Y/Y)
Sale of future
royalties, intellectual...
$5,000K
Net income
$8,752K
(-87.78%↓ Y/Y)
Fair value
adjustment related to...
$6,408K
(255.27%↑ Y/Y)
Stock-based compensation
expense
$2,969K
(-46.78%↓ Y/Y)
Accounts payable and
accrued expenses
$2,320K
(120.59%↑ Y/Y)
Discount and rebate
liabilities
$2,307K
(-24.31%↓ Y/Y)
Income tax expense
$703K
(-79.21%↓ Y/Y)
Other liabilities
$391K
(-80.36%↓ Y/Y)
Depreciation and
amortization expense
$364K
(-88.97%↓ Y/Y)
Prepaid expenses and
other current assets
-$149K
(-150.34%↓ Y/Y)
Fair value
adjustment related to...
$140K
(2700.00%↑ Y/Y)
Non-cash lease expense
$122K
Other long-term
assets
-$45K
Non-cash interest
expense
$1K
(-99.93%↓ Y/Y)
Net cash provided by
investing activities
$31,451K
(39.93%↑ Y/Y)
Net cash provided by
(used in) operating...
$17,032K
(244.06%↑ Y/Y)
Net cash (used in)
provided by financing...
$1,585K
(-46.95%↓ Y/Y)
Canceled cashflow
$22,757K
Canceled cashflow
$51,040K
Net increase in cash
and cash...
$49,726K
(257.05%↑ Y/Y)
Canceled cashflow
$342K
Purchases of investments
$22,540K
(-85.71%↓ Y/Y)
Purchases of property and
equipment
$217K
(-30.45%↓ Y/Y)
Gain on sale of future
royalties, intellectual...
$43,314K
Accounts and other
receivables
$5,740K
(-17.64%↓ Y/Y)
Accretion on investments
$595K
(-43.87%↓ Y/Y)
Settlement of royalties to
aquestive
-$500K
(gain) loss on foreign
currency exchange rates
$406K
(409.92%↑ Y/Y)
Operating lease
right-of-use assets
$234K
(-70.68%↓ Y/Y)
Inventories
$140K
(-76.11%↓ Y/Y)
Operating lease
liabilities
-$111K
(-114.88%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$342K
(-219.58%↓ Y/Y)
Back
Back
Cash Flow
ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC. (ZVRA)
source: myfinsight.com